Table 4 The relationship between post RP Gleason score, age, body mass index (BMI), prostate-specific antigen (PSA) and different fat measurements using Pearson correlation coefficient.

From: Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease

Correlations

  

NPFV

AFA

SFT

PSA

BMI

Biopsy GS

Post-op GS

Age

Pearson C.

0.154

0.046

−0.090

0.061

−0.149

0.133

0.147

Sig. (2-tailed)

0.050

0.561

0.256

0.444

0.064

0.092

0.062

N

162

162

162

162

156

162

162

NPFV

Pearson C.

1

0.129

0.042

0.036

0.117

0.331**

0.294**

Sig. (2-tailed)

 

0.101

0.596

0.645

0.146

0.000

0.000

N

162

162

162

162

156

162

162

AFA

Pearson C.

0.129

1

0.644**

0.207**

0.640**

0.098

0.046

Sig. (2-tailed)

0.101

 

0.000

0.008

0.000

0.213

0.563

N

162

162

162

162

156

162

162

SFT

Pearson C.

0.042

0.644**

1

0.162*

0.794**

0.062

−0.004

Sig. (2-tailed)

0.596

0.000

 

0.039

0.000

0.435

0.960

N

162

162

162

162

156

162

162

PSA

Pearson C.

0.036

0.207**

0.162*

1

0.121

0.169*

0.326**

Sig. (2-tailed)

0.645

0.008

0.039

 

0.132

0.031

0.000

N

162

162

162

162

156

162

162

BMI

Pearson C.

0.117

0.640**

0.794**

0.121

1

0.079

0.020

Sig. (2-tailed)

0.146

0.000

0.000

0.132

 

0.326

0.800

N

156

156

156

156

156

156

156

  1. *Correlation is significant at the 0.05 level (2-tailed).
  2. **Correlation is significant at the 0.01 level (2-tailed).
  3. NPFV = Normalised periprostatic fat volume; AFA = Abdominal fat area; SFT = Subcutaneous fat thickness; PSA = Prostate specific antigen; BMI = Body mass index; GS = Gleason score.